U.S. patent court deals setback to Allergan's Restasis strategy
(Reuters) - A U.S. administrative court said it has the authority to decide the validity of patents Allergan Plc transferred to a Native American tribe, dealing a setback to a strategy the company adopted to protect one of its best-selling medicines from generic competition.
AbstractNeuropathic pain (NeP) is an intractable pain caused by a lesion or disease of the somatosensory nervous system. NeP is often challenging to manage because most of the mechanisms remain to be elucidated. Recent investigations in the field of autoimmune neurology have demonstrated that specific autoantibodies against antigens in the somatosensory pathway can cause NeP. Detection of pathogenic autoantibodies in NeP adds to the understanding of the mechanism of pain, which might aid in the development of novel immunotherapies. Therefore, it is necessary to explore novel NeP ‐related autoantibodies to improve the man...
ConclusionSmaller tissue transfers are less prone to infections of the recipient site and present low LOS. For an POABP regime, the combination of 2nd and 3rd generation cephalosporins presents substantial results in recipient site infections. In cases of allergy, potential pathogens show adequate susceptibility to moxifloxacin.Clinical relevanceA combination of 2nd and 3rd generation cephalosporins may be used to prevent recipient sites in head and neck surgery.
Widespread use of nonmedical masks could reduce community transmission. But recommending their broad use could also cause a run on the kind of masks that health care workers desperately need.
Professional societies issue stern warning not to inappropriately prescribe meds for COVID - 19
Publication date: Available online 31 March 2020Source: The Journal of Allergy and Clinical Immunology: In PracticeAuthor(s): Suvina Amin, Mena Soliman, Andrew McIvor, Andrew Cave, Claudia Cabrera
Publication date: Available online 31 March 2020Source: The Journal of Allergy and Clinical Immunology: In PracticeAuthor(s): Bruce T. Miles, Sofianne Gabrielli, Ann Clarke, Harley Eisman, Greg Shand, Moshe Ben-Shoshan
Condition: Malaria, Malaria Vaccine, Insecticide-treated Bednets Interventions: Biological: RTS,S/AS01 malaria vaccine; Other: PBO bed nets Sponsors: Michigan State University; University of Malawi College of Medicine; University of Maryland, College Park; Boston University; National Institute of Allergy and Infectious Diseases (NIAID) Recruiting
Condition: Cow Milk Allergy Intervention: Dietary Supplement: Amino acid-based formula Sponsor: Assiut University Not yet recruiting
TUESDAY, March 31, 2020 -- Exclusive breastfeeding for the first three months of life may cut the risk for allergy and asthma later in childhood, according to a study published March 3 in Acta Paediatrica. Galya Bigman, Ph.D., from the University...